Astera Labs (NASDAQ:ALAB) Upgraded at Northland Securities

Northland Securities upgraded shares of Astera Labs (NASDAQ:ALAB) from a market perform rating to an outperform rating in a research note issued to investors on Monday, Marketbeat Ratings reports. They currently have $175.00 price objective on the stock.

Other equities analysts also recently issued reports about the stock. TD Cowen cut their price target on shares of Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a report on Wednesday, November 5th. Barclays reiterated an “equal weight” rating and issued a $155.00 target price on shares of Astera Labs in a research note on Monday, October 20th. Jefferies Financial Group boosted their target price on Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. Citigroup raised their price target on Astera Labs from $160.00 to $275.00 and gave the company a “buy” rating in a report on Wednesday, September 17th. Finally, Roth Capital boosted their price objective on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus price target of $184.82.

Astera Labs Stock Up 1.8%

ALAB stock opened at $142.01 on Monday. Astera Labs has a twelve month low of $47.13 and a twelve month high of $262.90. The company has a market cap of $23.99 billion, a PE ratio of 127.94, a price-to-earnings-growth ratio of 2.60 and a beta of 1.37. The business’s 50-day simple moving average is $188.74 and its 200 day simple moving average is $145.31.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same quarter in the prior year, the company posted $0.23 EPS. The business’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts anticipate that Astera Labs will post 0.34 EPS for the current year.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 90,459 shares of the stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief operating officer directly owned 1,599,750 shares in the company, valued at $231,467,827.50. This represents a 5.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the sale, the director directly owned 385,863 shares in the company, valued at approximately $66,858,482.01. This represents a 32.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 619,436 shares of company stock worth $96,530,060 over the last 90 days. 12.50% of the stock is currently owned by corporate insiders.

Institutional Trading of Astera Labs

Large investors have recently bought and sold shares of the business. Assetmark Inc. boosted its holdings in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the period. Oliver Lagore Vanvalin Investment Group acquired a new stake in shares of Astera Labs during the second quarter worth $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs in the 2nd quarter valued at $36,000. National Bank of Canada FI boosted its stake in Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after purchasing an additional 124 shares during the period. Finally, Wexford Capital LP bought a new position in Astera Labs during the 3rd quarter worth about $39,000. 60.47% of the stock is owned by institutional investors.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.